Scaffold Technology Market Expected to Reach $5.1 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Scaffold Technology Market," The scaffold technology market was valued at $1.02 billion in 2021, and is estimated to reach $5.09 billion by 2031, growing at a CAGR of 18% from 2022 to 2031.

Scaffolds mimic the extracellular matrix of the native tissue, recapitulating the in vivo milieu and allowing cells to influence their own microenvironments. They usually serve purposes such as allow cell attachment and migration, deliver & retain cells and biochemical factors, and exert certain mechanical & biological influences to modify the behavior of the cell phase.

In addition, scaffold can act as a delivery vehicle for exogenous cells and matrix for cell adhesion to facilitate certain unit cell processes (for example, mitosis, synthesis, migration) of cells in vivo or for cells seeded in vitro. It also serves as a barrier to prevent the infiltration of surrounding tissue that may impede the process of regeneration. Scaffold technology technique is gaining popularity in the healthcare research sector, owing to increased demand for body reconstruction procedures and tissue engineering.

Scaffold is a biomaterial that initiates tissue growth in regenerative medicine, and its presence allows cells to generate biological structural components of the extracellular matrix in culture environment. Moreover, natural polymers scaffold shows better fit to the microenvironment of tissues and promotes desirable cellular responses, degradability, and biocompatibility.

Depending on product type, the natural scaffold segment dominated the market in 2021, and is expected to continue this trend throughout the forecast period, owing to growing research in the field of tissue engineering and regenerative medicine to develop novel scaffolds for remodeling of biological tissues.

Based on type, the micro-porous scaffolds segment holds the largest market share, owing to advantages offered by micro-porous scaffold such as high product demand in tissue engineering for liver, bladder, nerve, skin, bone, cartilage, and ligament. Moreover, micro-porous scaffold enables organ-on-a-chip technology to enhance in vivo wound healing. Therefore, this segment is expected to dominate the product segment during the forecast period.

On the basis of application, the regenerative medicine segment is estimated to be the fastest-growing segment during the forecast period owing to successful advancements in regenerative medicine therapies.  

Based on end user, the market is segmented into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment dominated the scaffold technology market size in 2021, registering a CAGR of 18.2% from 2022 to 2031. This growth is attributed to upsurge in collaborations between academic institutions and biotechnology & pharmaceutical companies worldwide.

Several companies collaborate with the laboratories for conducting basic research to eventually reducing the overall time required for the completion of the research. Contract research laboratories segment is expected to grow rapidly by 2031, registering a CAGR of 18.6% during the forecast period, owing to the increased need to provide diagnostic services to biopharmaceutical companies and research laboratories for performing research activities.

By region, North America accounted for the largest market share in 2021, and is anticipated to maintain its dominance from 2022 to 2031 due to the presence of large pharmaceutical and biotechnology companies that use scaffold technology in 3D culture in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. Furthermore, rise in demand for organ transplantation and surge in R&D activities focused on technologically advanced solutions are predicted to fuel the adoption of 3D cell culture practices in the region.

In addition, surge in incidences of cancer has led the government to increase the funding and grants for R&D in the field of cancer, which may have a positive impact on the scaffold technology market trends. Moreover, strategic expansion of biotechnological and pharmaceutical companies has led to launch of advanced products, which is expected to augment the market growth in the coming years.

The report provides a comprehensive analysis of the key players that operate in the global scaffold technology market. The key companies profiled in the report include 3D Biotek LLC, Advanced Biomatrix, Inc., Agilent Technologies, Inc. (Biotek), BioVison, Incorporated, Corning Incorporated, Merck KGaA (Sigmaaldrich), PromoCell GmbH, Reprocell, Incorporation, Synthecon, Incorporated, and Thermo Fisher Scientific Inc.

KEY FINDINGS OF THE STUDY

• On the basis of product type, the natural scaffolds segment held 62.86% share in the global Scaffold Technology Market growth in 2021.
• On the basis of type, the micro-porous scaffolds segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
• On the basis of application, the cancer research segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
• On the basis of end user, the academic institutes segment held the largest share in biodegradable scaffold industry in 2021, and is expected to remain dominant throughout the forecast period.
• Region-wise, North America dominated the scaffold technology market share in 2021, and is expected to be dominant during the forecast period, owing to rise in incidences of cancer, increase in number of organ transplantation, and expansion of biotechnology & pharmaceutical companies.